A Phase 1, Randomized, Placebo-controlled, Single & Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Healthy Chinese Volunteers
Clinical trial NCT02750553 · COMPLETED
Trial details
- NCT number
- NCT02750553
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.